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KSHV K8 gene is activated by virally encoded transactivator RTA in delayed-early stage of viral reactivation. Three RTA-responsive elements
(RREs) were identified in the promoter. Among them, RRE-II was found to be the most critical cis-acting element for RTA transactivation. In this
report, the mechanism underlying RTA-mediated activation of the K8 delayed-early promoter was investigated. A DNA affinity purification study
demonstrated that RRE-II was bound by cellular protein RBP-Jκ, a sequence-specific DNA binding protein and a primary target of the Notch
signaling pathway. Inspection of the RRE-II sequence revealed a potential recognition sequence for RBP-Jκ (GTGAGAA) between the
nucleotides −102 and −108 relative to the transcription initial site. Removal or mutation of the motif abolished RBP-Jκ binding to the K8
promoter and as a consequence, RTA failed to bind to and activate the promoter. An essential role of RBP-Jκ in the transcription of the K8
promoter was demonstrated by diminishment of the promoter activity in RBP-Jκ-null murine embryonic fibroblasts. Taken together, RTA activates
the K8 promoter through an indirect binding mechanism, i.e. being recruited to the K8 promoter through interaction with RBP-Jκ bound to an
RBP-Jκ motif in the promoter.
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Gene expression regulationIntroduction
Kaposi's sarcoma-associated herpesvirus (KSHV), also
referred to as human herpesvirus-8 (HHV-8), is a gammaher-
pesvirus, belonging to Rhadinovirus genus (Chang et al., 1994;
Moore et al., 1996). This virus has been proven to be associated
with several malignancies including Kaposi's sarcoma (KS)
(Ambroziak et al., 1995), primary effusion lymphoma (PEL)
(Cesarman et al., 1995) and multicentric Castleman's diseases
(MCD) (Soulier et al., 1995).
The open reading frame K8 of KSHVencodes a bZip protein,
namely K8 protein or replication-associated protein (RAP) or
K-bZip (Lin et al., 1999; Zhu et al., 1999). Three functions have
been reportedly associated with this protein. (i) K8/RAP was
found to bind to the origin of viral lytic DNA replication (ori-
Lyt) of KSHVand its binding is absolutely required for the DNA⁎ Corresponding author. Fax: +1 215 898 8385.
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doi:10.1016/j.virol.2006.09.032replication (Lin et al., 2003; Wang et al., 2004b). (ii) K8/RAP
causes cell cycle arrest at G1 phase through induction of C/EBP
α and p21 (Wu et al., 2002). (iii) K8/RAP interacts with virally
encoded replication and transcription activator (RTA) and
represses the transcription of viral delayed-early genes by
RTA (Izumiya et al., 2003; Liao et al., 2003). The former
function in ori-Lyt-dependent DNA replication appears to be
required for viral lytic replication in the delayed-early stage,
while the latter two functions are needed in the immediate-early
stage. Therefore, K8/RAP is an important regulatory protein in
both immediate-early and delayed-early stages of reactivation
of KSHV.
Consistent with the functions of K8/RAP protein in the
immediate-early and delayed-early stages, the K8 gene was
found to be expressed in both stages during KSHV reactivation.
We previously reported that transcription of the K8 gene in
these two stages is controlled by two distinct promoters,
yielding two transcripts, an immediate-early mRNA of 1.5 kb
and a delayed-early mRNA of 1.3 kb. Transcription from the
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12-O-tetradecanoylphorbol-13-acetate (TPA), but was not
responsive to ORF50/RTA. The delayed-early promoter showed
little response to sodium butyrate and TPA, but can be fully
induced by ORF50/RTA (Wang et al., 2004a).
The current study focused on the mechanism of transactiva-
tion of the K8 delayed-early promoter by RTA. Our previous
study revealed three RTA responsive elements (RREs) in the K8
delayed-early (DE) promoter. The first RRE (designated K8
RRE-I) is located between −72 and −61 and contains a
functional C/EBP binding site. The second RRE (K8 RRE-II),
between −133 and −95, is a novel cis-acting element for K8
gene activation by RTA. The third RRE (K8 RRE-III), between
−171 and −161, shares a sequence homology with RRE-II. It
was shown that RRE-I had trivial effects in RTA transactivation
in BCBL-1, BJAB and BL41 cells, but contributed more to the
promoter activation in embryonic kidney fibroblast 239 cells. In
contrast, RRE-II was found to be a crucial cis-acting element
for RTA transactivation in BCBL-1, BJAB, BL41 and 293 cells
because deletion of RRE-II almost completely ablated tran-
scriptional activity in these cells (Wang et al., 2004a). A similar
observation of the roles of RRE-I and RRE-II in the activation
of the K8 DE promoter in B cells and non-B cells was also
reported by Seaman and Quinlivan (2003).
RTA is the most crucial factor for the switch of KSHV
between latency and lytic replication (reviewed in Dourmishev
et al., 2003). It has been shown that ectopic expression of RTA
in primary effusion lymphoma cell lines harboring latent KSHV
episome activates expression of downstream delayed-early and
late viral lytic genes and drives viral lytic cascade to completion
(Lukac et al., 1998; Sun et al., 1998). RTA activates viral lytic
genes through at least two distinct mechanisms, either by direct
binding to DNA or by an indirect binding mode. RTA
responsive elements (RREs) in PAN, K12 and ori-Lyt-
associated promoters were identified, and it was demonstrated
that RTA directly bound to these RREs with high affinities.
RREs in PAN, K12 and ori-Lyt promoters share a common
consensus motif (Chang et al., 2002; Song et al., 2002; Wang et
al., 2004b). RTA also acts on RREs in the promoter of K9, but
none of these RREs were found to be bound by RTA directly
(Ueda et al., 2002). An RRE in the ORF57 promoter has low
affinity for direct binding of RTA in an electrophoretic mobility
shift assay (EMSA), but encompasses strong binding sites for
cellular DNA binding protein RBP-Jκ, which mediates
cooperative transactivation (Lukac et al., 2001; Liang et al.,
2002). RBP-Jκ was also found to mediate RTA-driven
activation of the promoters of ORF6 (SSB), K14 (vGPCR),
LANA and RTA itself (Liang et al., 2002; Liang and Ganem,
2003; 2004; Lan et al., 2005). RBP-Jκ is a sequence-specific
DNA binding protein and a primary target of the Notch
signaling pathway. In the absence of a Notch signal, RBP-Jκ
acts as a transcriptional repressor. Ligand-mediated Notch
activation leads to the conversion of RBP-Jκ from a repressor to
a transcriptional activtor (reviewed in Mumm and Kopan, 2000;
Hayward, 2004). RTA, which appears to mimick a Notch signal,
activates some of its target promoters by binding to the
repression domain of RBP-Jκ and conferring the promoters anactive status (Liang et al., 2002). Besides RBP-Jκ, other cellular
factors such as Oct-1, C/EBP α, and K-RBP have also been
suggested to play roles in RTA transactivation in certain target
promoters (Sakakibara et al., 2001; Wang et al., 2001, 2003).
In this report, we further investigated the activation of K8
gene by RTA in delayed-early phase. We found that RTA
activates K8 delayed-early promoter mainly through an indirect
binding mechanism, i.e. being recruited to the K8 promoter by
interaction with RBP-Jκwhich is bound to an RBP-Jκ site in the
promoter.
Results
RBP-Jκ binds to K8 RRE-II and recruits RTA to the promoter
Given that the RRE-II has been shown to be the most critical
cis-acting element in the K8 DE promoter for RTA-mediated
transcriptional activity, we would further characterize it for the
mechanism of RTA-mediated transactivation through this RRE.
Since the RRE-II shows no sequence homology to the
consensus DNA sequence for direct RTA binding that derived
from RREs of PAN promoter (Song et al., 2002), K12 promoter
(Chang et al., 2002) and ori-Lyt-associated promoter (Wang et
al., 2004b), we speculated that RTA acts on the RRE-II through
an indirect DNA binding mechanism, whereby RTA is recruited
to the RRE-II through interaction with an as yet unidentified
factor. Thus, we sought to identify the factor by employing a
DNA affinity purification approach. A 132-bp DNA fragment
of the K8 promoter derived from the region between −161 and
−30 (PK8-wt) and its deletion mutant, in which the RRE-II
sequence has been deliberately deleted (PK8-Δ2), were
synthesized by PCR using PK8-DE250 plasmid DNA or its
RRE-II deletion mutant (PK8-DE250Δ2) as templates (Wang et
al., 2004a). One of the PCR primers was labeled with a biotin
residue at its 5′ end so that the PCR products were 5′
biotinylated. The PK8-wt DNA fragment contained RRE-I and
RRE-II motifs, while the PK8-Δ2 DNA carried RRE-I but no
RRE-II sequence. These biotinylated DNAs were coupled to
streptavidin-conjugated magnetic beads. The beads were
incubated with nuclear extract derived from TPA-induced
BCBL-1 cells. The bound materials were washed with
150 mM KCl-containing buffer and sequentially eluted with
300 mM, 500 mM and 1 M KCl. The eluted materials were
analyzed by Western blots with antibodies against some cellular
DNA binding proteins including RBP-Jκ, C/EBP α, C/EBP β,
Sp-1 and NF-κB. The result revealed that RBP-Jκ was bound to
wild-type K8 promoter DNA and eluted at the 500 mM KCl
step elution (Fig. 1). In contrast, RBP-Jκ was not able to bind to
the mutated promoter where RRE-II sequence had been deleted
(PK8-Δ2). Binding of RBP-Jκ in RRE-II of the K8 promoter
raised a possibility that RTA activates K8 DE promoter by
targeting RRE-II through interaction with an RBP-Jκ molecule.
TheWestern blotting with antibodies against C/EBP α and other
cellular proteins failed to detect their antigens in the eluted
materials (data not shown).
The DNA affinity purified materials were then analyzed for
RTA using a specific antibody against the protein. Western blot
Fig. 1. Identification of K8 promoter RRE-II binding proteins by using DNA
affinity purification. TPA-treated BCBL-1 nuclear extracts were subjected to
DNA affinity purification with immobilized DNA fragments of the K8 delayed-
early promoter (PK8-wt), the RRE-II deletion mutant of the promoter (PK8-Δ2),
and the ori-Lyt-associated promoter sequence (ori-RRE). After washing with
150 mM KCl-containing buffer, affinity-purified proteins were eluted with
300 mM KCl followed by 500 mM KCl. 5% of the eluted materials as well as
0.5% of the input material were resolved in a SDS-PAGE and analyzed by
Western blotting with various specific antibodies.
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500 mM KCl buffer, but did not bind to theΔ2 DNA. It appears
that RTA failed to bind to the promoter when RBP-Jκ was not
on the DNA. Taken together, our data suggest that cellular
protein RBP-Jκ binds to RRE-II DNA and recruits RTA to the
RRE-II in the K8 promoter by interacting with it. As a control,
ori-Lyt-associated promoter was not bound by RBP-Jκ, but
RTA can bind to it directly (Fig. 1).
To our surprise, our DNA affinity study did not detect RTA
in the material eluted from the Δ2 DNAwith 300 and 500 mM
KCl (Fig. 1). RTAwas also not found in the 1 M KCl eluate as
well as on the DNA-conjugated beads after elution (data not
shown). This result suggests that RTA apparently only binds to
RRE-II of the K8 promoter, but not to RRE-I in the condition
used in this study. In addition, C/EBP α was not detected in this
DNA affinity study with either the wild-type or Δ2 DNA
although RRE-I is present in both DNAs (data not shown).
RBP-Jκ recognition sequence is essential for RRE-II-mediated
transactivation of the promoter by RTA
Inspection of the DNA sequence within RRE-II revealed a
potential recognition sequence for RBP-Jκ (GTGAGAA)
between the nucleotides −102 and −108 relative to the
transcription initial site. This motif is not a prototypic RBP-Jκ
consensus sequence, but Liang and Ganem (2004) recently
showed that RBP-Jκ recognizes it in the K14/vGPCR
promoter. To confirm the role of the RBP-Jκ recognition
site in RTA-mediated transactivation of the K8 promoter, we
made a mutation in the K8 promoter, which altered the RBP-
Jκ recognition motif GTGAGAA to a BamHI recognition site
(Fig. 2A). This mutation was introduced into a K8 promoter–
reporter construct PK8-DE250 and the effect of this RBP-Jκ
motif mutation on RTA-mediated transactivation of the
promoter was analyzed using a luciferase assay. Reporter
constructs of wild-type K8 promoter (PK8DE-250), RBP-Jκ
site mutant (PK8DE-250mJκ) as well as RRE-I, RRE-II andRRE-III deletion mutants (PK8DE-250Δ1, Δ2 and Δ3) were
introduced into BL41 and 293 cells together with an RTA-
expressing vector (pCR3.1-ORF50) or empty pCR3.1 vector.
The result showed that (i) in agreement with previous data,
deletion of RRE-II caused a dramatic reduction of RTA-
mediated K8 promoter transactivation by 94% in 293 cells
and over 99% in BL41 cells; (ii) mutation of RBP-Jκ
recognition site brought about similar effects (95% reduction
in 293 cells and 99% in BL41 cells) as seen with RRE-II
deletion mutant (Fig. 2B and C). This result indicates that the
central theme of RRE-II is the RBP-Jκ recognition motif
which plays a critical role in the K8 promoter for RTA-
mediated transactivation.
RRE-II/RBP-Jκ-mediated RTA transactivation contributes most
to transcription of K8 delayed-early gene
Our data demonstrated that the RBP-Jκ motif resided in
RRE-II is a crucial cis-acting element for RTA activation of
K8 DE promoter. However, RRE-I was also reported to
contribute to the K8 promoter activation by RTA and shown
to be directly bound by purified RTA in vitro (Lukac et al.,
2001). Furthermore, a functional C/EBP α binding site
(designated C/EBP-II) was found within the RRE-I and
ectopic expression of C/EBP α was able to enhance RTA
transactivation of the K8 promoter in a transient reporter gene
assay as well as K8 gene expression in PEL cells (Wang et
al., 2003). These data suggest that the regulation of the K8
promoter might involve multiple mechanisms, including direct
DNA binding mechanism and indirect mechanisms with RBP-
Jκ and C/EBP α, respectively. However, in the DNA affinity
binding assay, we failed to detect the direct RTA binding and
C/EBP α-mediated indirect binding of RTA to RRE-I (Fig. 1).
One possible explanation for this result is that the affinities of
RTA directly binding to RRE-I and C/EBP α binding to the
RRE were low; the concentrations of RTA and C/EBP α in
the BCBL-1 nuclear extract were lower than the binding
constants (Kd's) for RTA-RRE-I and C/EBP α-RRE-I
interactions, so that RTA binding to RRE-I, either in a direct
mode or through C/EBP α, was not detected in the condition
used in our DNA affinity assay. To clarify this issue and
assess the contribution of RRE-I and RRE-II to the activation
of the K8 promoter by RTA, we examined these two RREs
that allows comparison of their contributions to RTA-
mediated activation of the promoter in parallel. BL-41 and
293 cells were transfected with RBP-Jκ and C/EBP α
expression vectors, respectively, as well as the combination
of RBP-Jκ or C/EBP α with RTA. The effects of these
cellular proteins on RTA-mediated K8 promoter activation
were examined using K8 promoter reporters that were
cotransfected into these cells. First, ectopic expression of
RBP-Jκ and C/EBP α alone (in the absence of RTA) did not
activate the K8 DE promoter in either BL41 or 293 cells
(Fig. 3). Second, cotransfection with RBP-Jκ and RTA
brought about small increases in the transcription of the K8
promoter–reporter in both cell lines. This suggests that the
physiological concentration of RBP-Jκ was saturated for
Fig. 2. Mutational analysis of RBP-Jκ binding motif in the K8 DE promoter. The K8 DE promoter and its derivatives including deletion mutants of each RRE and
substitutive mutant of RBP-Jκ are illustrated schematically in panel A. The potential RBP-Jκmotif is marked with a box and three RREs are underlined. BL41 (B) and
293 cells (C) were cotransfected with a K8 promoter-luciferase reporter or its mutants shown in panel A and pCR3.1-ORF50 or pCR3.1 empty plasmid. Luciferase
activities were analyzed by the dual-luciferase reporter assay. Relative luciferase activities were measured as fold activity induced by RTA relative to the basal level of
luciferase activity in cells that are cotransfected with blank plasmid pCR3.1, with the error bars representing standard deviations of the results from two independent
experiments.
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not have much effect on the promoter activity (Fig. 3). Third, the
contribution of endogenous C/EBPα to the K8 promoter activity
and the effects of ectopic expression of C/EBPα on the promoter
were found to vary between BL41 and 293 cells.
Introduction of C/EBP α and RTA expression vectors to
BL41 cells led to a substantial increase (4-fold) in transcrip-
tion of the K8 promoter reporter in comparison to transfection
with RTA alone. The effects of C/EBP α ectopic expression
on RTA-mediated transactivation were greater with the RRE-
II and RRE-III deletion mutants of the K8 promoter reporter,
20-fold with PK8-DE250Δ2 and 10-fold with PK8-
DE250Δ3, respectively. The effect diminished in the RRE-I
deletion of the reporter ((PK8-DE250Δ1), confirming that the
C/EBP α effect on the promoter was through interaction with
RRE-I that contains a functional C/EBP site (Wang et al.,
2003). This result can be explained as follows. The
physiological concentration of C/EBP α in BL41 cells is
perhaps much lower than the dissociation constant (Kd) of the
protein binding to RRE-I and therefore the contribution ofC/EBP α and RRE-I to the promoter activation is insignificant in
this type of cells. However, ectopic expression of C/EBP α
elevated the level of the protein in the cells so that C/EBP α
began to bind to RRE-I and recruited RTA to the RRE for
transactivation.
In contrast, ectopic expression of C/EBP α in 293 cells
brought about little change in transactivation of the K8
promoter by RTA. Although ectopic expression of C/EBP α is
found to enhance the RTA-mediated transactivation of the
promoter where RRE-II has been deleted (PK8-DE250Δ2),
the C/EBP α effect was very limited (2-fold). These data
suggest that endogenous C/EBP α has probably reached a
saturated concentration in 293 cells and is able to activate the
promoter by binding to RRE-I and recruiting RTA to the
promoter. It is worthy to note that although the physiological
concentrations of both RBP-Jκ and C/EBP α in 293 cells are
high enough for them to bind to their motifs, the contribution
of RBP-Jκ to the K8 promoter activity is obviously much
greater than that of C/EBP α because deletion of RRE-II or
mutation of RBP-Jκ resulted in loss of 94–95% of total promoter
Fig. 4. Contribution of RBP-Jκ to transactivation of the K8 DE promoter. Wild-
type (OT13) and RBP-Jκ-null (OT11) mouse embryonic fibroblast cell lines
were cotransfected with 100 ng of K8 promoter-luciferase reporters and 100 ng
RTA expression vector (pCR3.1-ORF50 or empty pCR3.1) or 100 ng of RBP-Jκ
expression vector or combination of pCR3.1-ORF50 and increasing amounts
(0–200 ng) of RBP-Jκ expression vector. (A) Luciferase activities were
analyzed by the dual-luciferase reporter assay. Relative luciferase activities were
measured as fold activity relative to the basal level of luciferase activity in cells
that are cotransfected with blank plasmids, with the error bars representing
standard deviations of the results from two independent experiments. (B)
Western blotting showing the levels of endogenous RBP-Jκ in OT13 cells, the
absence of endogenous RBP-Jκ in OT11 cells and ectopic expression of RBP-Jκ
in OT11 cells.
Fig. 3. Effects of ectopic expression of RBP-Jκ and C/EBP α on transcription
activity of the K8 DE promoter in BL41 and 293 cells. A K8 promoter-luciferase
reporter and its RRE deletion mutants were introduced into BL41 and 293 cells
with RBP-Jκ or C/EBP α expression vector alone or together with RTA
expression vector (pCR3.1-ORF50) or pCR3.1 empty plasmid. Luciferase
activities were analyzed by the dual-luciferase reporter assay. Relative luciferase
activities were measured as fold activity relative to the basal level of luciferase
activity in cells that are cotransfected with blank plasmids pGL3 and pCR3.1,
with the error bars representing standard deviations of the results from two
independent experiments.
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less than 50% of the activity in 293 cells (Figs. 2C and 3B).
Inability of transactivation of the K8 promoter in RBP-Jκ-null
cells and restoration of the promoter activity by ectopic
expression of RBP-Jκ
To further analyze the role of RBP-Jκ in activation of the K8
promoter by RTA, we obtained a mouse embryonic fibroblast
(MEF) cell line derived from an RBP-Jκ−/− mouse (Oka et al.,
1995). This RBP-Jκ-null line (OT11) and its wild-type
counterpart OT13 were used to analyze activation of the K8
promoter and its deletion mutants by RTA. Reporter constructs
of the K8 promoter as well as its mutant derivatives wereintroduced into OT11 and OT13 cells along with RTA-
expression vector pCR3.1-ORF50 or empty pCR3.1 plasmid.
As shown in Fig. 4, RTA was able to fully activate the K8
promoter (PK8-DE250) in wild-type OT13 cells. In contrast,
cotransfection of RBP-Jκ−/−MEF OT11 cells with K8 reporter
construct and RTA-expression vector resulted in very low
luciferase activity, indicating that RTA itself was not able to
efficiently activate the K8 promoter in the absence of RBP-Jκ.
Co-expression of RTA and increasing amounts of RBP-Jκ in
OT11 cells resulted in progressively higher levels of K8
promoter activities in the wild-type promoter (pK8-DE250) and
its RRE-I deletion mutant (pK8-DE250Δ1) (Fig. 4A). How-
ever, ectopic expression of RBP-κ alone did not activate the K8
promoter at all (Fig. 4A). The RBP-Jκ-dependent transactiva-
tion of the K8 promoter by RTAwas greatly compromised when
RRE-II-deleted (PK8-DE250Δ2) or RBP-Jκ motif-mutated
reporter constructs (pK8-DE250mJκ) were used in the assay
in RBP-Jκ-null cells, confirming the role of RBP-Jκ motif in
RRE-II in the K8 promoter activity (Fig. 4A). The expression of
RBP-Jκ in the transfected cells was monitored by Western blot
with an antibody specific to RBP-Jκ (Fig. 4B). We noticed that
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restored RTA-mediated transcriptional activity of the K8
promoter, the levels of the promoter activity were lower than
that in wild-type OT13 cells. We think that it may be caused by
a compromised RBP-Jκ activity (either in DNA binding or in
interaction with RTA) associated with the attachment of a myc
tag to the protein or it may just represent a difference between
two cell lines (OT11 vs. OT13). Nevertheless, the inability of
transactivation of the K8 promoter by RTA in RBP-Jκ-null cells
and restoration of the transcriptional activity of the promoter by
ectopic expression of RBP-Jκ conclusively demonstrated an
essential role of RBP-Jκ in transactivation of the K8 delayed-
early promoter.
Finally, although it was firmly shown that RBP-Jκ is
absolutely required for activation of the K8 and many other
promoters by RTA, it has not been demonstrated whether
RTA cannot bind to RRE-II in the K8 promoter but is
recruited to the promoter through interaction with RBP-Jκ
molecules. By taking advantage of RBP-Jκ-null MEF cells
(OT11), we studied interaction of RTA with the K8 promoter
DNA in the absence and the presence of RBP-Jκ molecules
using a DNA affinity purification approach. The K8 promoter
DNA (132 bp) immobilized to magnetic beads was incubated
with nuclear extracts from OT11 and OT13 cells. After
washing, bound proteins were eluted with 500 mM KCl and
analyzed by Western blotting with anti-RBP-Jκ and anti-RTA
antibodies. RTA was found to be able to bind the DNA withFig. 5. Binding of RTA to the K8 promoter is dependent on the presence of
RBP-Jκ. RBP-Jκ-null MEF cells (OT11) were transfected with RTA-, RBP-Jκ-
expression vectors or both. The wild type MEF cells (OT13) were also
transfected with RTA-expression vector (pCR3.1-ORF50) or empty vector
(pCR3.1) as controls. The nuclear extracts of the transfected cells were
subjected to DNA affinity purification with immobilized DNA fragments of the
K8 delayed-early promoter (PK8-wt). After washing with 150 mM KCl-
containing buffer, affinity-purified proteins were eluted with 500 mM KCl.
10% of the eluted materials as well as 1% of the input material were resolved in
a SDS-PAGE and analyzed by Western blotting with antibodies against RTA
and RBP-Jκ.OT13 nuclear extract, but not able to bind with OT11 nuclear
extract, confirming that RTA does not bind to K8 promoter
DNA in the absence of RBP-Jκ (Fig. 5). When the nuclear
extracts from OT11 cells that had been transfected with RTA-
and RBP-Jκ-expression vectors are used in the assay, RTA
was found to be able to bind the DNA with RBP-Jκ. RBP-Jκ
binds to the K8 promoter DNA regardless the presence of
RTA molecules (Fig. 5). Taken together, our results clearly
demonstrated that binding of RTA to the K8 promoter
through RRE-II and the activation of the promoter is
dependent on the presence of RBP-Jκ. RBP-Jκ plays an
essential role in activate the K8 DE promoter.
Discussion
In this study, we attempted to reveal the mechanisms
underlying activation of the K8 gene during the reactivation of
KSHV. The K8 delayed-early promoter is known to be activated
by the transcription activator RTA (Lukac et al., 2001; Seaman
and Quinlivan, 2003; Wang et al., 2004a). In this report, we
demonstrated that RTA is recruited to one of its responsive
elements, namely RRE-II, in the K8 promoter through
interaction with RBP-Jκ, a Notch signal transcription factor,
and activates the promoter. The RBP-Jκ-mediated RTA
transactivation is the most crucial regulation in the activation
of the gene. The following observations are relevant to these
conclusions. (i) RBP-Jκ was found to bind the K8 DE promoter
at the RRE-II in a DNA affinity assay. (ii) A mutagenesis study
showed that the recruitment of RTA to the promoter was
dependent on the binding of RBP-Jκ on the promoter at the
RRE-II site. (iii) Transient transactivation studies in RBP-Jκ-
null mouse MEF (OT11) cells showed that the K8 DE promoter
cannot be activated by RTA in the absence of RBP-Jκ, while the
promoter can be activated by nearly 250-fold in the syngeneic
control cells (OT13). These data undeniably demonstrated that
RBP-Jκ is essential for activation of the K8 DE promoter by
RTA.
Accumulating evidence indicates that RTA activates its
target genes through at least two modes of action: direct
DNA binding and indirect mechanisms. RTA was shown to
bind to the RREs in the PAN, K2, K12, ori-Lyt promoters
(Chang et al., 2002; Deng et al., 2002; Song et al., 2002;
Wang et al., 2004b), but more RREs in other promoters are
not directly bound by RTA (Liang et al., 2002; Liang and
Ganem, 2004; Sakakibara et al., 2001; Ueda et al., 2002;
Wang et al., 2003). In latter cases, cellular factors were
found to be required for RTA transactivation function. The
cellular factors that are reportedly involved in RTA-mediated
transactivation include Oct-1, C/EBP α, K-RBP and RBP-Jκ
(Liang et al., 2002; Sakakibara et al., 2001; Ueda et al.,
2002; Wang et al., 2001; Wang et al., 2003). Among them,
RBP-Jκ has been reported to be involved in RTA-mediated
transcription of ORF57 (Mta), ORF6 (SSB), K14 (vGPCR),
LANA and ORF50/RTA itself (auto-activation) (Liang et al.,
2002; Liang and Ganem, 2004; Lan et al., 2005). In
addition, RTA also induces cellular CD21 and CD23a gene
expression through interaction with RBP-Jκ molecule on
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CD23a core promoter, respectively (Chang et al., 2005). In
this report, the K8 delayed-early promoter was found to be
activated by RTA through interaction with RBP-Jκ. This
finding, together with previous reports regarding involvement
of RBP-Jκ in RTA-mediated activation of many other viral
lytic promoters, suggest that interaction with RBP-Jκ is a
common mechanism by which RTA activates lytic genes
during reactivation. A central role of RBP-Jκ in KSHV
reactivation has been demonstrated by the inability of KSHV
reactivation in the RBP-Jκ-null murine embryonic fibroblast
cell line. The results showed that the reactivation of lytic
gene expression, viral DNA replication, and the release of
progeny viruses were dramatically inhibited in the absence of
RBP-Jκ (Liang and Ganem, 2003). The RBP-Jκ–RTA
interaction is critical for lytic viral replication.
The RRE-I-mediated activation of K8 promoter by RTA has
been investigated previously. This element was shown to be a
direct binding site for purified RTA (Lukac et al., 2001). The
element also contains a functional binding site for C/EBP α and
a cooperative transactivation of the K8 promoter by RTA and C/
EBP α has been demonstrated (Wang et al., 2003). Although we
did not detect direct RTA binding or C/EBP α binding to the
promoter DNA in the DNA affinity assay (despite that RRE-I
was present in the biotinylated promoter DNAs, i.e. wt andΔ2),
it does not necessarily suggest any discrepancy between our
present data and the results previously published. (i) We were
able to demonstrate the contribution of RRE-I to the activation
of the promoter by RTA in our transient transactivation assay.
Deletion of RRE-I from the K8 promoter resulted in a reduction
in RTA transactivation by nearly 50% in 293 cells, which is
consistent with previous publication (Lukac et al., 2001;
Seaman and Quinlivan, 2003; Wang et al., 2004a). However,
the contribution of RRE-I to the promoter in B cells (BCBL-1,
BJAB and BL41 cells) appeared to be less significant. (ii) One
explanation for the failure to detect the association of C/EBP α
with the DNA probe of the K8 promoter might be the
concentration of C/EBP α in the nuclear extract as well as in
B cells is probably much lower than the dissociation constant
(Kd) of the protein to RRE-I DNA. This notion is supported by
the fact that C/EBP α-mediated RTA activation through RRE-I
was dramatically increased with ectopic expression of C/EBP α
in B cells (Fig. 3A). Thus, although the functional consequence
of the weak RTA binding to RRE-I can be detected by luciferase
reporter assay, the binding was too weak to be detected in our in
vitro experimental condition with the nuclear extract from TPA-
induced BCBL-1 cells. (iii) It is conceivable that binding
affinity of RTA to RRE-I DNA either by a direct DNA binding
or through interaction with a C/EBP α molecule is much lower
than that of RTA to RRE-II through interaction with RBP-Jκ, as
RRE-II displays a greater effect than RRE-I on the gene
activation by RTA based on the results of the transient promoter
activation assay. (iv) Finally, our observation may suggest a
synergy in RTA binding to all RREs. It is possible that
association of RTA with RRE-I could be facilitated if RTA has
bound to RRE-II through RBP-Jκ. Deletion of RRE-II may not
only abolish the association of RTA/RBP-Jκ to this element, butalso weaken the binding of RTA to RRE-I. Although RRE-II is
the most crucial cis-acting element, binding of RTA to RRE-I
(as well as RRE-III) may synergistically enhance transcription
of the K8 promoter. Transcriptional synergy among cis-acting
elements and transactivators has been demonstrated in EBV
ZTA transactivation system (Chi et al., 1995). Therefore, our
finding on the major role of RRE-II in K8 promoter activation
and the involvement of RBP-Jκ in the recruitment of RTA to the
promoter present no discrepancy, but an addition to our
knowledge about RTA activation of the K8 delayed-early
promoter.
Based on the data and observations from the current and
previous studies, a model for K8 DE promoter activation by
RTA can be established as follows. (i) RTA activates the K8
DE promoter mainly through RRE-II by interaction with
RBP-Jκ protein. (ii) RTA also binds weakly to RRE-I either
by direct DNA binding or through interaction with C/EBP α.
However, the RTA bound to RRE-I may be synergized with
the RTA/RBP-Jκ on RRE-II or vice versa to provide the
maximal transcription efficiency of the K8 promoter. (iii)
Although RRE-II is the most crucial cis-acting element for
RTA-mediated transactivation of the K8 promoter, the
contribution of RRE-I may vary due to differential availability
of certain cellular factors (such as C/EBP α) in different types
of cell, providing opportunities that allow K8 gene being
efficiently regulated in different cell environments. Consider-
ing that KSHV naturally persists in B cells and endothelial
cells, the differential regulation of a viral gene such as K8 in
different cell types would be of biological significance.
Materials and methods
Cell culture
BCBL-1 (Renne et al., 1996) cells were obtained from the
NIH AIDS Research and Reference Reagent Program and
grown in RPMI 1640 medium supplemented with 10% fetal
bovine serum. BL-41 (an EBV-negative, KSHV-negative
Burkitt's lymphoma cell line) cells were grown in RPMI
1640 medium supplemented with 10% fetal bovine serum.
Human embryonic kidney fibroblast 293 cells were main-
tained in Dulbecco's modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum. Mouse RBP-
Jκ−/− (OT11) and WT (OT13) embryonic fibroblast cell lines
(Oka et al., 1995) were kindly provided by T. Honjo (Kyoto
University, Kyoto, Japan) and were grown in high-glucose
DMEM supplemented with 10% fetal bovine serum and
100 U/ml of mouse interferon gamma (PBL Biomedical
Laboratories, Piscataway, NJ).
Reporter plasmids and expression vectors
Reporter plasmids (PK8-DE250, PK8-DE250Δ1, PK8-
DE250Δ2 and PK8-DE250Δ3) were constructed and described
previously (Wang et al., 2004a). PK8-DE250mJκwas generated
using a PCR-based site-directed mutagenesis system, namely
QuickChange Multi (Stratagene). Briefly, a pair of overlapping
26 Y. Wang, Y. Yuan / Virology 359 (2007) 19–27oligonucleotides K8-RRE2 quick-1 (5′-TCT ACT TAA AAT
AGC TCA TTT GGA TCC GAA TCT GGT TGA TTG TGA
CTA-3′) and K8-RRE2 quick-2 (5′-TAG TCA CAATCA ACC
AGA TTC GGA TCC AAA TGA GCT ATT TTA AGT AGA-
3′), that contain desired mutations toward opposite directions,
were used in a high-fidelity PCR with PK8-DE250 as a
template. After PCR, the parental DNA template was removed
by complete digestion with restriction enzyme DpnI, which did
not degrade PCR-sythesized DNA. The PCR product was used
to transform E. coli competent cells. The mutation was verified
by DNA sequencing.
RTA expression vector (PCR3.1-ORF50) was constructed
and described previously (Wang et al., 2004a). RBP-Jκ
expression vector (pA3M-RBP-Jκ-myc) was provided by Erle
Robertson (University of Pennsylvania) and C/EBP α expres-
sion vector (pSG5-Flag-C/EBP α) by Gary Hayward (Johns
Hopkins University).
DNA affinity purification and assay
Biotinylated DNA fragments of the K8 DE promoter
(PK8-wt and PK8-Δ2) were synthesized by PCR using PK8-
DE250 plasmid DNA or its RRE-II deletion mutant (PK8-
DE250Δ2) as templates and two oligonucleotides as primers.
The oligonucleotides were K8-8 (5′-CAG TTT GGT GCA
AAG TGG AGT TAA CC-3′) and K8-DE-Biotin (5′-biotin-
GTC GAC AAC GGA GGA AAT ACC A-3′). The resultant
biotinylated PCR fragments were coupled to streptavidin-
conjugated magnetic beads (Dynal, Oslo, Norway) and then
incubated with nuclear extracts prepared from tetradecanoyl
phorbol acetate (TPA)-induced BCBL-1 cells or transfected
mouse embryonic fibroblast OT11 and OT13 cells for 2 h at
25 °C. The bound materials were washed four times in D150
buffer (20 mM HEPES [pH 7.9], 20% glycerol, 0.2 mM
EDTA, 150 mM KCl, 1 mM dithiothreitol, 1 mM phenyl-
methylsulfonyl fluoride, 0.05% NP-40) and then progressively
eluted with D300 (same as above, except 300 mM KCl),
D500 (500 mM KCl), and D1000 (1 M KCl). The affinity-
purified materials were assayed by Western blot analysis with
various antibodies.
Antibodies and Western blotting
Rabbit polyclonal antibody to ORF50/RTAwas provided by
David Lukac (UMDNJ). Polyclonal antibody against RBP-Jκ
was provided by Ke Lan and Erle Robertson (University of
Pennsylvania). Polyclonal antibodies against C/EBP α, C/EBP
β and NF-κB (p65) were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Polyclonal anti-Sp1
antibody was purchased from UPSTATE (Lake Placid, NY).
Cell extracts or DNA affinity eluates were resolved on
4–20% SDS-PAGE and transferred to Hybond-ECL nitrocel-
lulose membrane (Amersham). The membranes were blocked
in 5% dry milk in PBST buffer and then incubated with diluted
primary antibodies at room temperature for 2 h or 4 °C
overnight. Anti-rabbit immunoglobulin G antibody conjugated
to horseradish peroxidase (Amersham) was used as thesecondary antibody. The ECL chemiluminescence system
(Amersham) was used for detection.
DNA transfection and luciferase assays
To transfect B cells, 10 μg luciferase reporter construct, 1 μg
pRL-TK plasmid and 3 μg pCR3.1-ORF50 (or pCR3.1 vector)
were mixed with 107 BL-41 or BJAB cells in OPTI-MEM
medium (GIBCO-BRL) and electroporated (250 V, 960 μF)
with a Genepulser II (Bio-Rad, Hercules, CA). Electroporated
cells were then transferred to RPMI 1640 medium supplemen-
ted with 10% serum and grown for 48 h. The pRL-TK plasmid
was included as an internal control, which constitutively
expresses Renilla luciferase.
To transfect human embryonic kidney 293 and mouse
embryonic fibroblast cells, subconfluent cells grown in 24-well
plates were transfected with 100 ng of pGL-3 reporter, 10 ng
pRL-TK reporter and 100 ng pCR3.1-ORF50 using Qiagen
Effectene transfection kit. Cells were harvested at 48 h post-
transfection for luciferase assay.
The dual luciferase reporter assay system (Promega) was
used to examine the responsiveness of the promoters to RTA.
Transfected cells were washed once with 1× PBS and
suspended in 400 μl of 1× passive lysis buffer. Cells were
frozen-thawed once and centrifuged in mirocentrifuge for
1 min. Supernatants were assayed for firefly luciferase and
Renilla luciferase activities using a TD-20/20 luminometer with
dual auto injector (Turner Designs). The luciferase assays were
carried out according to the manufacturer's instruction
(Promega).
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